Former Chief Financial Officer · ABEONA THERAPEUTICS INC. (ABEO)

Christine Silverstein

FY2019 is the first fiscal year CompBrief holds for Christine Silverstein as a named executive officer of ABEONA THERAPEUTICS; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2019

$1,000,225

Salary $350,000Stock awards $0Bonus $84,000

3rd of 3 named executive officers at Abeona Therapeutics by FY2019 total.

3 named officers on file for ABEONA THERAPEUTICS, FY2019

Christine Silverstein’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 1 equity grant, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how ABEONA THERAPEUTICS’s whole pay program stands against its peers

  • ABEONA THERAPEUTICS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ABEO→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 9, 2021 (DEF 14A).

Free

Get Christine Silverstein’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Christine Silverstein compensation by year

ABEONA THERAPEUTICS Summary Compensation Table · the one fiscal year held
In US dollars, as ABEONA THERAPEUTICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019
Salary$350,000
Bonus$84,000
Stock awards$0
Option awards$566,225
Non-equity incentive$0
Pension and deferred compensation$0
All other$0
Total$1,000,225

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ABEONA THERAPEUTICS INC. DEF 14A filed April 9, 2021, accession 0001140361-21-012309, and prior-year filings. Open the filing on EDGAR.

How this page was built: the ABEONA THERAPEUTICS INC. filed document, accession 0001140361-21-012309. Every figure is read from that document and cited to the page and table it appears in. Filed April 9, 2021.

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
RSU80,000$125,600—
Option8,730—$1.28
Option57,837—$1.28
Option102,163—$1.28
Option46,664—$1.28
Option10,413—$1.28

Per the Outstanding Equity Awards at Fiscal Year-End table in ABEONA THERAPEUTICS INC.'s FY2020 proxy; value at the fiscal year-end close, as the company printed it.

ABEONA THERAPEUTICS’s named executive officers, FY2019

as the company reported each
Named executive officerRoleFY2019 total
João SiffertFormer Chief Executive Officer, Head of Research & Development and Chief Medical Officer$2,326,061
Steven RouhandehFormer Executive Chairman$1,480,019
Christine Silverstein · this pageFormer Chief Financial Officer$1,000,225

Board service

ABEONA THERAPEUTICS board · FY2021–FY2025
Director compensation in US dollars, as ABEONA THERAPEUTICS reports it. Most recent year first; a dash means the company reported no figure in that column.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$50,000$200,000—$0$250,000
FY2024$53,832$181,048—$0$234,880
FY2023$53,750$271,143—$0$324,893
FY2022$50,000$37,386——$87,386
FY2021$50,000$57,499$53,600—$161,099

Each year as the company reported it in ABEONA THERAPEUTICS's director compensation table. Totals are the company's own disclosed totals.

How this board is paid

Company policy: ABEONA THERAPEUTICS pays directors a $50,000 cash retainer and $200,000 in Restricted Stock. As stated in ABEONA THERAPEUTICS's FY2025 proxy.

The full ABEONA THERAPEUTICS compensation record

free company brief

This page is one person within ABEONA THERAPEUTICS's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are ABEONA THERAPEUTICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Christine Silverstein's compensation dossier · One-time report. No refunds.